Status:

UNKNOWN

At-risk and vulNerable Individuals To Infection With COVID-19 and ProActive inTervention With intEgrated Health and Social Care

Lead Sponsor:

Unity Health Toronto

Collaborating Sponsors:

Ontario Ministry of Health and Long Term Care

Ontario Medical Association

Conditions:

Emotional Distress

Quality of Life

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

This randomized control trial aims to explore a data-driven, proactive approach to identifying patients at greatest risk during the pandemic, and assess the impact of an embedded System Navigator in a...

Eligibility Criteria

Inclusion

  • At-risk and vulnerable patients of primary care organizations who are 60+ AND have one or more of:
  • chronic condition (diabetes, CHF, CAD, COPD or asthma)
  • serious mental illness (schizophrenia or bipolar disorder)
  • anticipated to live in poverty and/or be homeless/underhoused

Exclusion

  • patients unable to provide informed consent

Key Trial Info

Start Date :

February 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2024

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT05197608

Start Date

February 25 2022

End Date

March 1 2024

Last Update

December 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Michael's Hospital

Toronto, Ontario, Canada, M5B1W8